Kilitch Drugs (India) consolidated net profit declines 25.67% in the December 2025 quarter

Explore Business Standard
Associate Sponsors
Co-sponsor

Sales decline 4.20% to Rs 53.81 crore
Net profit of Kilitch Drugs (India) declined 25.67% to Rs 4.43 crore in the quarter ended December 2025 as against Rs 5.96 crore during the previous quarter ended December 2024. Sales declined 4.20% to Rs 53.81 crore in the quarter ended December 2025 as against Rs 56.17 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var.Sales53.8156.17 -4 OPM %11.4315.54 -PBDT6.539.06 -28 PBT5.608.25 -32 NP4.435.96 -26Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
First Published: Feb 12 2026 | 9:19 AM IST